Key result
Shoulder disarticulation and adjuvant therapy yields 1-year recurrence-free survival in a secondary angiosarcoma case.
Why the study?
Angiosarcoma secondary to post-irradiation and chronic lymphedema is rare and aggressive with poor prognosis, requiring better understanding of clinical features to distinguish it from benign or other malignant diseases.
Case Report (n=3)
Answers are grounded in this paper and cite their sources.
In patients with a history of irradiation and chronic lymphedema presenting with suspicious skin lesions, prompt biopsy is essential to diagnose aggressive secondary angiosarcoma.
INTRODUCTION: Angiosarcoma secondary to post-irradiation and lymphedema is rare, but it is aggressive with a poor prognosis. It is essential to understand these patients' clinical features and distinguish them from benign diseases or other malignant tumors. PATIENT CONCERNS: Three patients who had radiotherapy for cancer treatment and chronic lymphedema admitted to the hospital with specific skin lesions at upper or lower extremities. DIAGNOSIS: Excisional biopsies revealed prominent, highly atypical cells with a vasoformative area, composed of atypical, large epithelioid cells with vesicular nuclei, prominent nucleoli, and mitoses. Immunohistochemistry revealed diffuse expression of endothelial cell markers suggestive of angiosarcoma. INTERVENTIONS: One patient had shoulder disarticulation with wide excision with adjuvant radiotherapy and chemotherapy and other 2 discontinued the treatment. OUTCOMES: After the treatment, one patient was transferred to rehabilitation department for shoulder disarticulation prosthesis fitting without recurrence sign for 1 year. Two patient refused further treatment and was lost to follow-up. CONCLUSION: In cases of patients with irratiation and chronic lymphedema, clinical findings suggestive of angiosarcoma, biopsy and imaging studies should be performed as soon as possible.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted a case report in Angiosarcoma secondary to post-irradiation and chronic lymphedema (n=3). Post-irradiation and chronic lymphedema was evaluated on Recurrence. Among three patients with angiosarcoma secondary to post-irradiation and chronic lymphedema, one treated with shoulder disarticulation and adjuvant therapy remained recurrence-free for 1 year.
Synapse has enriched 10 related papers. Consider them for comparative context: